These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 4976365)
21. Large-scale production of indefinitely propagated cell lines. Cooper PD Natl Cancer Inst Monogr; 1968 Dec; 29():63-7. PubMed ID: 5720812 [No Abstract] [Full Text] [Related]
22. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments. Vasington PJ Natl Cancer Inst Monogr; 1968 Dec; 29():205-6. PubMed ID: 4976358 [No Abstract] [Full Text] [Related]
23. Neoplastic properties of animal cell lines--general comments. Macpherson I Natl Cancer Inst Monogr; 1968 Dec; 29():295-6. PubMed ID: 4976360 [No Abstract] [Full Text] [Related]
24. Experience with an established cell line for veterinary vaccine production. Brown AL Natl Cancer Inst Monogr; 1968 Dec; 29():523-6. PubMed ID: 4305440 [No Abstract] [Full Text] [Related]
25. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments. Fellowes ON Natl Cancer Inst Monogr; 1968 Dec; 29():209-14. PubMed ID: 5720794 [No Abstract] [Full Text] [Related]
26. Experience with vaccines--summary. Koprowski H; Jackson GG Natl Cancer Inst Monogr; 1968 Dec; 29():565-6. PubMed ID: 5720809 [No Abstract] [Full Text] [Related]
27. Comments on technology of production--continuous cell lines. Daniels WF Natl Cancer Inst Monogr; 1968 Dec; 29():71-2. PubMed ID: 5720813 [No Abstract] [Full Text] [Related]
28. Tissue and medium antigens in vaccines. Coriell LL Natl Cancer Inst Monogr; 1968 Dec; 29():179-91. PubMed ID: 4976862 [No Abstract] [Full Text] [Related]
29. Neoplastic properties of animal cell lines. Methods for determining neoplastic properties. Foley GE Natl Cancer Inst Monogr; 1968 Dec; 29():217-28. PubMed ID: 4888929 [No Abstract] [Full Text] [Related]
30. Detection of viral latency by biochemical methods. Green M Natl Cancer Inst Monogr; 1968 Dec; 29():375-89. PubMed ID: 4976865 [No Abstract] [Full Text] [Related]
35. Karyologic characteristics of the WI-38 diploid cell system--general comments. Rubin BA; Minecci LC; Tint H Natl Cancer Inst Monogr; 1968 Dec; 29():97-104. PubMed ID: 5720816 [No Abstract] [Full Text] [Related]
36. Tissue and medium antigens in vaccines--discussion. Feldman HA Natl Cancer Inst Monogr; 1968 Dec; 29():193-4. PubMed ID: 5720791 [No Abstract] [Full Text] [Related]
37. Neoplastic properties of animal cell lines. Methods for determining neoplastic properties--discussion. Sandberg AA Natl Cancer Inst Monogr; 1968 Dec; 29():233-6. PubMed ID: 5252583 [No Abstract] [Full Text] [Related]
38. Blood group antigens in virus vaccines. Franks D; Dawson A Natl Cancer Inst Monogr; 1968 Dec; 29():195-9. PubMed ID: 4888928 [No Abstract] [Full Text] [Related]
39. The need for a standardised cell substrate for virus vaccine production. Perkins FT Ann Ist Super Sanita; 1969; 5(1):82-9. PubMed ID: 5382315 [No Abstract] [Full Text] [Related]
40. Neoplastic properties of animal cell lines. Methods for determining neoplastic properties--discussion. Dawe CJ Natl Cancer Inst Monogr; 1968 Dec; 29():229-32. PubMed ID: 5720795 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]